 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction/Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products/Modifiers/Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Electrolytes/Minerals/Metals/Vitamins
|
|
Gastrointestinal Agents
|
|
Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
|
|
Genitourinary Agents
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
|
Hormonal Agents, Suppressant (Adrenal)
|
|
Hormonal Agents, Suppressant (Pituitary)
|
|
Hormonal Agents, Suppressant (Thyroid)
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
 Ophthalmic Agents
|
Ophthalmic Anti-allergy Agents
|
Azelastine [DG:DG01036]
|
Bepotastine [DG:DG01327]
|
Cromolyn [DG:DG00098]
|
Emedastine [DG:DG01144]
|
 D07890 Emedastine (INN)
D02249 Emedastine difumarate (JP17/USP)
|
Epinastine [DG:DG01116]
|
Lodoxamide [DG:DG01143]
|
Nedocromil [DG:DG01038]
|
Olopatadine [DG:DG01039]
|
Ophthalmic Antiglaucoma Agents
|
Ophthalmic Anti-inflammatories
|
Ophthalmic Prostaglandin and Prostamide Analogs
|
Ophthalmic Agents, Other
|
|
Otic Agents
|
|
Respiratory Tract/Pulmonary Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
USP Drug Classification